Deeper Knowledge, Faster

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Fish and Richardson
Johnson and Johnson
Cantor Fitzgerald

Generated: December 14, 2017

DrugPatentWatch Database Preview

DANAZOL Drug Profile

« Back to Dashboard

When do Danazol patents expire, and what generic alternatives are available?

Danazol is a drug marketed by Am Therap, Barr, and Lannett. and is included in three NDAs.

The generic ingredient in DANAZOL is danazol. There are eight drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the danazol profile page.
Drug patent expirations by year for DANAZOL

Pharmacology for DANAZOL

Drug ClassAndrogen
Mechanism of ActionAndrogen Receptor Agonists

Medical Subject Heading (MeSH) Categories for DANAZOL

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
Am TherapDANAZOLdanazolCAPSULE;ORAL071569-001Dec 30, 1987DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
LannettDANAZOLdanazolCAPSULE;ORAL077246-001Sep 28, 2005ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
BarrDANAZOLdanazolCAPSULE;ORAL074582-001Aug 9, 1996ABRXNoYes► Subscribe► Subscribe► Subscribe► Subscribe
BarrDANAZOLdanazolCAPSULE;ORAL074582-003May 29, 1998ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
BarrDANAZOLdanazolCAPSULE;ORAL074582-002May 29, 1998ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
LannettDANAZOLdanazolCAPSULE;ORAL077246-003Apr 19, 2007ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
LannettDANAZOLdanazolCAPSULE;ORAL077246-002Apr 19, 2007ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Cantor Fitzgerald
Boehringer Ingelheim
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch: